1.086SEK-1.63%Mkt Cap: 35.40M $P/E: —Today
Intervacc AB (publ) develops novel veterinary vaccines for animals in Sweden. The company's product pipeline includes Strangvac, a vaccine against equine strangles for horses; INV274, antigens for a vaccine against strep…